Jean Hausser Lab

The field of cancer has blossomed during the last decade, thanks to advances in genome technology and to successful application of fundamental insights from immunology to the clinic. Cancer genomics studies have revealed how tumors differ in their molecular make-up. These differences can explain why different tumors respond to different drugs, and suggest how to personalize therapy. Decades of immunology research have revealed how the immune system protects the organism against cancer and explored the molecular signals that coordinate immune response. These fundamental insights are now starting to bear fruit in the clinic in the form of immunotherapy.

At the same time, these advances have produced new challenges. One challenge is that cancer cells can escape anti-cancer therapy, especially in advanced cancer patients. Another challenge is that only ~20% of patients benefit from immunotherapy, in a limited number of cancer types.

Our research has the potential to impact both challenges.

Evolutionary constraints on cancer cells

Within a tumor, single cancer cells express different genes. These differences can provide resistance against anti-cancer therapy because a given therapy may fail to eliminate the diversity of cancer cells. We are interested in mapping the evolutionary limits of this diversity, and in exploring how these limits can be exploited to treat heterogeneous tumors.

We previously researched the evolutionary constraints of solid tumors. We found that tumors from different cancer types face universal trade-offs and that these trade-offs provide a theoretical framework to integrate gene expression, drug sensitivities and genetic alterations. We are now interested in mapping the evolutionary trade-offs faced by single cancer cells.

Universal cancer tasks, evolutionary trade-offs, and the function of driver mutations. Jean Hausser, Pablo Szekely, Noam Bar, Hila Sheftel, Carlos Caldas, Uri Alon. Nature Communications 2019.

Tumor heterogeneity and the evolutionary trade-offs of cancer. Jean Hausser, Uri Alon. Nature Reviews Cancer 2020.

Quantitative rules in tumor biology

We research quantitative rules in tumor biology. We aim to formulate these rules in the form of equations that state how key tumor properties relate to each other: cellular composition of the tumor, functional heterogeneity among cells found in the tumor, spatial organization, tumor growth rate, tumor size, shedding rate of metastatic cells, and so on. Finding mathematical order in the complexity of the tumor micro-environment could support diagnostics, prognosis and inform the design of immunotherapy in the future, much like the laws of mechanics and aerodynamics presently support the design of cars and airplanes. It could also enhance ongoing efforts to apply artificial intelligence and machine-learning techniques to cancer, for example by providing constraints to artificial intelligence and identify new features for machine learning.

In the past, we researched quantitative rules in gene regulation. We now apply this research approach to tumor biology. By doing so, we hope to explain why certain immunotherapies fail on certain tumors and suggest what therapies may be effective.

Central dogma rates and the trade-off between precision and economy. Jean Hausser, Avi Mayo, Leeat Keren, Uri Alon. Nature Communications 2019, 10(68).

Time-scales and bottlenecks in microRNA mediated regulation of gene expression. Jean Hausser, Afzal Pasha Syed, Nathalie Selevsek, Erik van Nimwegen, Lukasz Jaskiewicz, Ruedi Aebersolf and Mihaela Zavolan. Molecular Systems Biology 2013, 9:711.

We employ a systems biology approach that combines computation and experiments:

• developing new data analysis approaches
• performing mouse experiments to follow tumors in time and characterize their response to therapeutic or genetic perturbation
• physics-inspired mathematical modeling

A full list of our publications is available on Google Scholar.

Jean Hausser
principal investigator (CV)
jean.hausser@scilifelab.se

Antony Cougnoux
staff scientist (immunology, cancer)
antony.cougnoux@scilifelab.se

Jakob Rosenbauer
EMBO post-doctoral fellow (physics)
jakob.rosenbauer@scilifelab.se

Alper Eroglu
PhD student (bioinformatics)
alper.eroglu@scilifelab.se

Louise Gsell
lab engineer (computational biology)
louise.gsell@scilifelab.se

Anissa El Marrahi
lab engineer (computational biology)
anissa.el@scilifelab.se

Mathilda Stigenberg
master student (bioinformatics)

Felix Waern
master student (bioinformatics)

Sofie Blahova
master student (bioengineering)

Raziyeh Mohseni
bachelor student (bioinformatics)

Petter Säterskog (2021-2023)
post-doctoral fellow (theoretical physics)

Loay Mahmoud (2021-2023)
research assistant (experimental biomedicine)
position after the lab: PhD student, NTNU Trondheim

Ziqi Kang (2022-2023)
master thesis student, research assistant (bioinformatics)
position after the lab: PhD student, Helsinki University

Iva Sutevski (2022-2023)
research assistant (biology)
position after the lab: PhD student, KTH Stockholm

Benjamin Maier (2021-2022)
visiting student (molecular life science)
position after the lab: PhD student, EMBL Heidelberg

Javier Escudero Morlanes (2021-2022)
master student (molecular life science)
position after the lab: research engineer, KTH/SciLifeLab Stockholm

Christina Bekiari (2022)
master student (biomedicine)
position after the lab: research assistant, Stockholm University/SciLifeLab

Guilhem Panneau (2021-2022)
research assistant (computational biology)
position after the lab: PhD student, University of Lausanne

Paloma Araceli Ruiz de Castroviejo Teba (2021)
visiting student (biomedicine)
position after the lab: product development scientist, Basic Genomics Stockholm

Fabio Lipreri (2020-2021)
research assistant (computer science)
position after the lab: data scientist, FrescoFrigo Milano

Letizia Orsini (2020-2021)
research assistant (biostatistics)
position after the lab: biostatistician, Karolinska Institutet

Axel de Tonnac (2020-2021)
consultant (bioengineering / bioinformatics)
position after the lab: sales executive, Sophia Genetics Lausanne

Tagore Sanketh Bandaru (2020)
master thesis student (molecular life science)
position after the lab: PhD student, University Hospital Basel

Maximilian Reck (2020)
master thesis student (molecular life science)
position after the lab: PhD student, University of Edinburgh

Fredrik Carlsson (2020)
summer student and developper
position after the lab: medical student, Karolinska Institutet

David Alber (2020)
research student (computational physics)
position after the lab: data scientist, IBM Vienna

Panos Kalogeropoulos (2020)
summer student (molecular life science)
position after the lab: PhD student, Stockholm University

We are currently looking for:

• Postdoctoral fellows Email Jean about 1. which of your research project was most exciting to you so far and why, 2. why you'd like to join us (1000 words max) and 3. attach a concise CV.
• PhD students interested in combining experiments with data analysis and theory More information.
• Master students enrolled in biology / biomedical programs or computational programs (bioinformatics, physics, applied mathematics, computer science, engineering, ...).
  Email Jean about 1. what course or projects you most enjoyed in your studies so far, 2. why you'd like to join us (1000 words maximum), and 3. attach a concise CV.

The lab is located at Karolinska Institutet and SciLifeLab in Stockholm, Sweden. Within Karolinska Institutet, we are affiliated to the department of Cell and Molecular Biology.

Visiting address

Gamma 6, Science for Life Laboratory, Tomtebodavägen 23A, 17165 Solna, Sweden

Mailing address

Science for Life Laboratory, Box 1031, 17121 Solna, Sweden